Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2003
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353636A1 Novel couplers for use in oxidative hair dyeing
10/22/2003EP1144423B1 Bis-terpyridine-platinum(ii) complexes
10/22/2003EP1140803B1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/22/2003EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003CN1451011A 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450047A Process for preparation of cyclic diketones
10/22/2003CN1125051C Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/22/2003CN1125050C Metalloproteinase inhibitors
10/22/2003CN1125049C New crystal modification N of torasemide
10/22/2003CN1125048C Method for producing isoureas
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1125030C Halogenated acrylates polymers derived therefrom
10/22/2003CN1125023C Substance for inducing cell death
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635767 Synthesis of heteroarylamine intermediate compounds
10/21/2003US6635766 Process for the preparation of arylamides of heteroaromatic carboxylic acids
10/21/2003US6635765 Processes for preparing torsemide intermediate
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2060326C Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084930A1 Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003WO2003037311A3 Method for treating retroviral infections
10/16/2003WO2003020241A3 Functional powders for oral delivery
10/16/2003WO2003011828A3 3-pyridylether rerivatives and their use as analgesics
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002007673A3 Calcilytic compounds
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195310 Chain transfer agents for raft polymerization in aqueous media
10/16/2003US20030195258 Taxol enhancer compounds
10/16/2003US20030195236 Heterocyclic imines such as 2-methyl-3-toluoyloxy-4-formyl-5-hydroxymethylpyridine, used for prophylaxis of vitamin B6 deficiency, cardiovascular disorders or melanomas
10/16/2003US20030195233 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -N-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders
10/16/2003US20030195232 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195200 Compounds, their preparation and use
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
10/16/2003US20030195112 Process for producing 2-(4-pyridyl)ethanethiol
10/16/2003US20030194748 Method for labeling with tritium
10/16/2003US20030194717 Mass labels
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_
10/15/2003EP1352901A2 Process for the preparation of cyclic diketones
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1352032A1 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351939A1 Coupler/developer and coupler/coupler hybrid dyes and coupler/developer and coupler/coupler hybrid dye intermediates
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351912A2 Substituted stilbenes, their reactions and anticancer activity
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1351685A2 Stabilized formulation of selective ligands of retinoic acid gamma-receptors
10/15/2003EP1351684A2 Compounds and methods for promoting smoking cessation
10/15/2003EP0916651B1 Phenylalkylcarboxylic acid derivatives
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003CN1449640A Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such
10/15/2003CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
10/15/2003CN1449383A Process for the preparation of 2-aminomriordan peter dominic ethylpyridines
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449276A Primary intermediates for oxidative coloration of hair
10/15/2003CN1449273A Antimicotic nail varnish composition
10/15/2003CN1448791A Novel photosensitive compound, resin and composition
10/15/2003CN1448123A Non-spherical and non-platelet pyrithione salts
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124268C Process for preparing aminopyrimidine sulfate by reducing pyrimidine derivative containing nitroso
10/15/2003CN1124263C Stabilised monomer composition
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 633